Headline
The latest stories from AHA Today.
The Department of Health and Human Services Aug. 27 announced it will award more than $558 million to support maternal health initiatives.
The AHA, 340B Health and the American Society of Health-System Pharmacists last week filed an amicus brief in a federal district court in Missouri, defending the state's law protecting 340B pricing for contract pharmacy arrangements.
If Johnson & Johnson moves forward with its plan to undermine the 340B Drug Pricing Program by unilaterally imposing a rebate model rather than the longstanding upfront discount model, the Health Resources and Services Administration should take “immediate enforcement action,” including…
The Health Resources and Services Administration Aug. 29 announced that it awarded a contract to the American Institutes for Research to support the Organ Procurement and Transplantation Network Board of Directors.
The FBI, Cybersecurity and Infrastructure Agency and the Department of Defense Cyber Crime Center Aug. 29 issued a joint advisory to warn of Iranian-based cyber actors leveraging unauthorized network access to U.S. organizations, including health care organizations, to facilitate, execute and…
The U.S. Department of Health and Human Services will not appeal its loss in American Hospital Association v. Becerra. The AHA, joined by the Texas Hospital Association, Texas Health Resources, and United Regional Health Care System, last November sued HHS to bar enforcement of a new rule adopted…
If Johnson & Johnson moves forward with its plan to undermine the 340B Drug Pricing Program by unilaterally imposing a rebate model rather than the longstanding upfront discount model, the Health Resources and Services Administration should take “immediate enforcement action,” including…
Cybersecurity experts from the AHA and Microsoft discuss the urgent need to build a cyber-strong workforce, particularly in rural hospitals and health systems, and how methods such as re-skilling can sustain permanent cyber readiness.
AHA Aug. 23 has named James “Scott” Gee as deputy national advisor for cybersecurity and risk.
Johnson & Johnson announced Aug. 23 that it would be fundamentally changing the way it makes 340B pricing available for two of its most popular products, Stelara and Xarelto.